CA19-9 in Potentially Resectable Pancreatic Cancer: Perspective to Adjust Surgical and Perioperative Therapy

Author： Hartwig Werner Strobel Oliver Hinz Ulf Fritz Stefan Hackert Thilo Roth Constanze Büchler Markus Werner Jens

ISSN： 1068-9265

Source： Annals of Surgical Oncology, Vol.20, Iss.7, 2013-07, pp. : 2188-2196

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

RE: CA 19-9 in Potentially Resectable Pancreatic Cancer: Perspective to Adjust Surgical and Preoperative Therapy

By Bold Richard

Annals of Surgical Oncology, Vol. 20, Iss. 7, 2013-07 ,pp. : 2108-2110

Springer Publishing Company

Access to resources Recommend Favorite

Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant Chemoradiation

By Katz Matthew

Annals of Surgical Oncology, Vol. 17, Iss. 7, 2010-07 ,pp. : 1794-1801

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic Impact of Perioperative Serum CA 19-9 Levels in Patients with Resectable Pancreatic Cancer

By Kondo Naru

Annals of Surgical Oncology, Vol. 17, Iss. 9, 2010-09 ,pp. : 2321-2329

Springer Publishing Company

Access to resources Recommend Favorite

Preoperative CA 19-9 and the Yield of Staging Laparoscopy in Patients with Radiographically Resectable Pancreatic Adenocarcinoma

By Maithel Shishir

Annals of Surgical Oncology, Vol. 15, Iss. 12, 2008-12 ,pp. : 3512-3520

Springer Publishing Company

Access to resources Recommend Favorite

Biomarkers for pancreatic cancer: promising new markers and options beyond CA 19-9

By Ballehaninna Umashankar Chamberlain Ronald

Tumor Biology, Vol. 34, Iss. 6, 2013-12 ,pp. : 3279-3292

Springer Publishing Company

Access to resources Recommend Favorite